Pills containing live bacteria on the horizon Taking a pill full of live bacteria does not sound like a medicine that your doctor would, or could, prescribe – but it might soon be. In the last decade, gut microbiome research has drawn a lot of attention and funding, but it was not clear whether any therapies would come out of it any time soon. Synlogic, Inc in Cambridge, MA developed a live bacterial therapy to treat phenylketonuria,
Scientists work together to create more effective medicines Advances continue to progress personalised medicine, a field in which drugs are tailored to patients’ needs based on their genetic information. Historically, simply screening patients’ genomes enabled this trend but more recently, synthetic nucleotide-based medicines have taken this a step further. Nucleotide-based medicines use artificial DNA and RNA (nucleotides) to target cellular genetic information directly, shutting off genetic diseases at their source.